These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9082680)
1. [Value of beta-blocker therapy in treatment of coronary heart disease and sudden cardiac death with special reference to carvedilol]. Zehender M; Just H Z Kardiol; 1996; 85 Suppl 7():23-9. PubMed ID: 9082680 [TBL] [Abstract][Full Text] [Related]
2. A review of carvedilol arrhythmia data in clinical trials. Kowey PR J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573 [TBL] [Abstract][Full Text] [Related]
4. [Estimation of effectiveness of the prevention of sudden cardiac death in patients with myocardial infarction]. Nakashidze NM; Machavariani PT Georgian Med News; 2006 Jun; (135):81-4. PubMed ID: 16905817 [TBL] [Abstract][Full Text] [Related]
5. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients. Sackner-Bernstein JD Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231 [TBL] [Abstract][Full Text] [Related]
6. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Dunn CJ; Lea AP; Wagstaff AJ Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087 [TBL] [Abstract][Full Text] [Related]
7. [Therapy with beta blockers in heart failure. Recent studies of carvedilol]. Böhm M; Erdmann E Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561 [No Abstract] [Full Text] [Related]
8. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study]. Ertl G; Nitschmann S Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581 [No Abstract] [Full Text] [Related]
9. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker. DiNicolantonio JJ; Hackam DG Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523 [TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results. Doughty RN; Sharpe N Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949 [TBL] [Abstract][Full Text] [Related]
11. [Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents]. Isnard R Ann Cardiol Angeiol (Paris); 2002 Jan; 51(1):48-50. PubMed ID: 12510669 [No Abstract] [Full Text] [Related]
12. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET. Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A; Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279 [TBL] [Abstract][Full Text] [Related]
13. [Beta-blockers and heart failure--a critical view]. Erdmann E Z Kardiol; 1996; 85 Suppl 7():35-8. PubMed ID: 9082682 [TBL] [Abstract][Full Text] [Related]
14. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure]. Buchwald A; Unterberg C; van der Does R; Wiegand V Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100 [TBL] [Abstract][Full Text] [Related]
15. Carvedilol for heart failure: more than just a beta-blocker? Cleland JG Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451 [TBL] [Abstract][Full Text] [Related]
16. Carvedilol [Coreg]. Kukin M Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163 [No Abstract] [Full Text] [Related]
17. COMET: a proposed mechanism of action to explain the results and concerns about dose. Coca SG; Buller GK Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889 [TBL] [Abstract][Full Text] [Related]
19. A risk-benefit assessment of carvedilol in the treatment of cardiovascular disorders. Louis WJ; Krum H; Conway EL Drug Saf; 1994 Aug; 11(2):86-93. PubMed ID: 7946002 [TBL] [Abstract][Full Text] [Related]
20. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule. Strein K; Sponer G Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]